Skip to main content
. 2018 Jul 23;10:2223–2229. doi: 10.2147/CMAR.S168409

Table 1.

Demographic, clinical, and operative indications of patients with TN Bethesda category III

Parameters A: Total study group (n=127) B: Noncancer (n=114) C: Cancer (n=13) p-value (B vs C)
Gender 0.165
 Male 22 (17.3) 18 (15.8) 4 (30.8)
 Female 105 (82.7) 96 (84.2) 9 (69.2)
Age (years) 51.0±15.0 49.5±15.9 52.5±14.1 0.520
Age 1.000
 <45 years 45 (35.4) 41 (35.9) 4 (30.8)
 ≥45 years 82 (64.6) 73 (64.1) 9 (69.2)
Final diagnosis <0.0001a
 Goiter 57 (44.9) 57 (50.0)
 Thyroiditis 12 (9.5) 12 (10.5)
 Adenoma 45 (35.4) 45 (39.5)
 Cancer 13 (10.2) 0 (0.0) 13 (100.0)
Type of surgery <0.0001a
 Nonradical 118 (92.9) 114 (100.0) 4 (30.8)
 Radical 9 (7.1) 0 (0.0) 9 (69.2)
Reoperation needed <0.0001a
 No 123 (96.9) 114 (100.0) 9 (69.2)
 Yes 4 (3.1) 0 (0.0) 4 (30.8)

Notes:

a

Statistically significant at p<0.05. Descriptive data are presented as number (%) or mean ± SD.

Abbreviation: TN, thyroid nodule.